BIRC2, CPTAC-790 - CPTAC Assay Portal (original) (raw)

Please include the following statement when referencing the CPTAC Assay Portal

We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
BIRC2 API1, IAP2, MIHB, RNF48
Sequence Length (AA) Molecular Weight (Da)
618 69900
Protein Name
Baculoviral IAP repeat-containing protein 2
Sources
UniProt PhosphoSitePlus ® GeneCards Human Protein Atlas

Protein Sequence hover to view complete sequence

CPTAC-790: View additional AVEDISSSR data

CPTAC-791: View additional LGDSPIQK data

10 20 30 40 50
MHKTASQRLF PGPSYQNIKS IMEDSTILSD WTNSNKQKMK YDFSCELYRM
60 70 80 90 100
STYSTFPAGV PVSERSLARA GFYYTGVNDK VKCFCCGLML DNWKLGDSPI
110 120 130 140 150
QKHKQLYPSC SFIQNLVSAS LGSTSKNTSP MRNSFAHSLS PTLEHSSLFS
160 170 180 190 200
GSYSSLSPNP LNSRAVEDIS SSRTNPYSYA MSTEEARFLT YHMWPLTFLS
210 220 230 240 250
PSELARAGFY YIGPGDRVAC FACGGKLSNW EPKDDAMSEH RRHFPNCPFL
260 270 280 290 300
ENSLETLRFS ISNLSMQTHA ARMRTFMYWP SSVPVQPEQL ASAGFYYVGR
310 320 330 340 350
NDDVKCFCCD GGLRCWESGD DPWVEHAKWF PRCEFLIRMK GQEFVDEIQG
360 370 380 390 400
RYPHLLEQLL STSDTTGEEN ADPPIIHFGP GESSSEDAVM MNTPVVKSAL
410 420 430 440 450
EMGFNRDLVK QTVQSKILTT GENYKTVNDI VSALLNAEDE KREEEKEKQA
460 470 480 490 500
EEMASDDLSL IRKNRMALFQ QLTCVLPILD NLLKANVINK QEHDIIKQKT
510 520 530 540 550
QIPLQARELI DTILVKGNAA ANIFKNCLKE IDSTLYKNLF VDKNMKYIPT
560 570 580 590 600
EDVSGLSLEE QLRRLQEERT CKVCMDKEVS VVFIPCGHLV VCQECAPSLR
610 618
KCPICRGIIK GTVRTFLS

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node

to view detailed assay information below

All other points link out to UniProt


Phosphorylation Acetylation Ubiquitylation Other

loading

Loader


Assay Details for CPTAC-790 Collapse assay details

Data source: Panorama

Official Gene Symbol

BIRC2

Peptide Sequence

AVEDISSSR

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

165

Peptide End

173

CPTAC ID

CPTAC-790

Peptide Molecular Mass

962.4669

Species

Homo sapiens (Human)

Assay Type

Direct PRM

Matrix

Pooled patient derived xenograft breast tumor digest

Submitting Laboratory

Washington University in St. Louis

Submitting Lab PI

Reid Townsend


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

TripleTOF 5600+ (SCIEX)

Internal Standard

Peptide

Peptide Standard Purity

Crude

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

2DPlus nano-LC (Eksigent)

Column Packing

ChromXP C18-CL, 3 µm, 120 Å

Column Dimensions

200 µm x 15 cm

Flow Rate

800 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y4 (1+) | 11.4 | 6.1 | 5 | 11.2 | 3.9 | 5 | 16 | 7.2 | 7.1 | 15 | 15 | 15 | | y5 (1+) | 8 | 6.5 | 3.7 | 9.7 | 6.4 | 4 | 12.6 | 9.1 | 5.4 | 15 | 15 | 15 | | y6 (1+) | 7.6 | 8.9 | 3.2 | 7.2 | 8.8 | 3.6 | 10.5 | 12.5 | 4.8 | 15 | 15 | 15 | | y7 (1+) | 6.2 | 5 | 5.2 | 7.1 | 4.5 | 7 | 9.4 | 6.7 | 8.7 | 15 | 15 | 15 | | sum | 4.2 | 4.1 | 2.5 | 3.3 | 4 | 3.1 | 5.3 | 5.7 | 4 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-791 Collapse assay details

Data source: Panorama

Official Gene Symbol

BIRC2

Peptide Sequence

LGDSPIQK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

95

Peptide End

102

CPTAC ID

CPTAC-791

Peptide Molecular Mass

856.4654

Species

Homo sapiens (Human)

Assay Type

Direct PRM

Matrix

Pooled patient derived xenograft breast tumor digest

Submitting Laboratory

Washington University in St. Louis

Submitting Lab PI

Reid Townsend


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

TripleTOF 5600+ (SCIEX)

Internal Standard

Peptide

Peptide Standard Purity

Crude

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

2DPlus nano-LC (Eksigent)

Column Packing

ChromXP C18-CL, 3 µm, 120 Å

Column Dimensions

200 µm x 15 cm

Flow Rate

800 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y3 (1+) | 27.1 | 16.2 | 12.4 | 28.1 | 17.7 | 15.5 | 39 | 24 | 19.8 | 15 | 15 | 15 | | y4 (1+) | 8.4 | 7.4 | 5.6 | 8.1 | 7.3 | 4.7 | 11.7 | 10.4 | 7.3 | 15 | 15 | 15 | | y5 (1+) | 7.4 | 4.2 | 4.9 | 10 | 4.4 | 4 | 12.4 | 6.1 | 6.3 | 15 | 15 | 15 | | y6 (1+) | 10.4 | 7.4 | 6.4 | 9.7 | 8 | 8.5 | 14.2 | 10.9 | 10.6 | 15 | 15 | 15 | | y7 (1+) | 6.4 | 5.9 | 4.2 | 7.1 | 4.6 | 5.4 | 9.6 | 7.5 | 6.8 | 15 | 15 | 15 | | b5 (1+) | 18.7 | 11.4 | 11.3 | 21.1 | 13.4 | 11.3 | 28.2 | 17.6 | 16 | 15 | 15 | 15 | | b3 (1+) | 27.2 | 17.8 | 14 | 27.5 | 16.9 | 14.5 | 38.7 | 24.5 | 20.2 | 15 | 15 | 15 | | sum | 2.1 | 4 | 2.4 | 2.7 | 3.1 | 3.1 | 3.4 | 5.1 | 3.9 | 15 | 15 | 15 |



Additional Resources and Comments